Process for forming Form 2 ranitidine hydrochloride

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260707, C07D30752

Patent

active

046721339

ABSTRACT:
A novel crystal form of ranitidine (N-[2-[[[5-(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl-N'-methyl-2- nitro-1,1-ethenediamine) hydrochloride, designated Form 2, and having favorable filtration and drying characteristics, is characterized by its infra-red spectrum and/or by its x-ray powder diffraction patterns.

REFERENCES:
patent: 4233302 (1980-11-01), Martin-Smith et al.
patent: 4279819 (1981-07-01), Price et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for forming Form 2 ranitidine hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for forming Form 2 ranitidine hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for forming Form 2 ranitidine hydrochloride will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1829814

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.